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 Dear Editor,
 We read with interest an article about inappropriate pre-
scribing to elderly patients in an internal medicine ward1 and 
a letter to the editor regarding the same paper.2
 We developed a similar study in the Portuguese primary 
care setting with a nation-wide representative sample of 
757 elderly patients in accordance to its distribution in Por-
tuguese health regions and we found that 77% of them were 
on ≥ 5 medications (with a mean of 8.2) and that 68% had 
at least one potentially inappropriate medication according 
the to 2015 Beers Criteria (with a mean of 1.72). The most 
common potentially inappropriate pharmacological classes 
were proton pump inhibitors (45.6%), non-steroid anti-in-
flammatory agents (34.5%) and benzodiazepines (27.3%).
 As such, we were also surprised with the low proportion 
of inappropriate prescribing at admission and at discharge 
reported in the study. One of the explanations, that was al-
ready reported,2 is the restricted number of pharmacological 
classes used.
 This does raise many questions. 
 Are we managing the various problems of our popula-
tion in the best way?
 Is it necessary to rethink the polypharmacy cut-off since 
with the aging of the population there is an increase in the 
number of chronic diseases3,4 and consequently an increase 
in the number of drugs necessary to control them? Do we 
have to practice according to the guidelines or according to 
our clinical judgement of pathophysiology?
 Does this definition of five drugs for polypharmacy put 
people at a higher risk of undermedication, instead of over-
medication?5 Shouldn’t we think of a new definition for poly-
pharmacy that isn’t the same for all people, but which takes 
into account the burden of disease that it is subject to? E.g. 
does it make sense to use the same polypharmacy cut-off 
for a healthy individual and a post-myocardial infarction pa-
tient?5
 We consider this issue as fundamental, since as already 
mentioned the management of multimorbidity and polyphar-
macy (more specifically of potentially inappropriate medica-
tion)6,7 are essential pillars in the provision of health care 
nowadays, both in primary and secondary care. 
 So this raises the question of time since, in medical edu-
cation, when should this topic be addressed and by whom?
 It is also important to analyze if there are differences 
between the work at the different health care levels regard-
ing the management of multimorbidity, polymedication and 
potentially inappropriate medication. Are we all working to-
wards the same goal?
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